Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Resistance of Streptococcus suis Isolates from the Czech Republic during 2018-2022

K. Nedbalcova, I. Kucharovicova, M. Zouharova, K. Matiaskova, N. Kralova, M. Brychta, B. Simek, T. Pecha, H. Plodkova, J. Matiasovic

. 2022 ; 11 (9) : . [pub] 20220907

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22023348

Grantová podpora
RO0518 Ministry of Agriculture
QK1810193 Ministry of Agriculture

A determination of susceptibility/resistance to antimicrobials via serotype was carried out in 506 field isolates of Streptococcus suis, originating from pig farms in the Czech Republic in the period 2018-2022. A very high level of susceptibility of S. suis isolates was found to amoxicillin, in combination with clavulanic acid and sulfamethoxazole potentiated with trimethoprim. None of the tested isolates were resistant to these antimicrobial substances. Only two isolates were found to be intermediately resistant to enrofloxacin in 2020. With regard to ceftiofur, one isolate was intermediately resistant in 2020 and 2022, and two isolates were intermediately resistant in 2018 and 2021. A low level of resistance was detected to ampicillin (0.6% in 2021) and to florfenicol (1.15% in 2019; 1.3% in 2022). With regard to penicillin, a medium level of resistance was detected in 2018 (10.6%), but a low level of resistance was found in the following years (7.0% in 2019; 3.1% in 2020; 3.3% in 2021; 3.9% in 2022). On the contrary, a high or very high level of resistance was found to tetracycline (66.0% in 2018; 65.1% in 2019; 44.35% in 2020; 46.4% in 2021; 54.0% in 2022). Using molecular and serological methods, serotype 7 (16.4%) was determined to be predominant among S. suis isolates, followed by serotypes 1/2, 2, 9, 4, 3, 1, 29, 16, and 31 (10.7%; 8.5%; 5.7%; 5.5%; 4.5%; 4.3%; 3.6%; 3.4%; 3.4%, respectively). Other serotypes were identified among the investigated strains either rarely (up to 10 cases) or not at all. A relatively high percentage of isolates were detected as non-typeable (79 isolates; 15.6%). Dependence of resistance upon serotype assignment could not be proven in all but serotype 31, wherein all isolates (n = 17) were resistant or intermediately resistant to clindamycin, tilmycosin, tulathromycin, and tetracycline. The resistance to clindamycin and tetracycline may be related to the high consumption of these antibiotics on pig farms at present or in previous years. Macrolides (tilmicosin and tulathromycin) and tiamulin are not suitable for the treatment of streptococcal infections, but are used on pig farms to treat respiratory infections caused by gram-negative bacteria, so they were included in the study.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22023348
003      
CZ-PrNML
005      
20221031095251.0
007      
ta
008      
221010s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/antibiotics11091214 $2 doi
035    __
$a (PubMed)36139993
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Nedbalcova, Katerina $u Veterinary Research Institute, Hudcova 296/70, 621 00 Brno, Czech Republic
245    10
$a Resistance of Streptococcus suis Isolates from the Czech Republic during 2018-2022 / $c K. Nedbalcova, I. Kucharovicova, M. Zouharova, K. Matiaskova, N. Kralova, M. Brychta, B. Simek, T. Pecha, H. Plodkova, J. Matiasovic
520    9_
$a A determination of susceptibility/resistance to antimicrobials via serotype was carried out in 506 field isolates of Streptococcus suis, originating from pig farms in the Czech Republic in the period 2018-2022. A very high level of susceptibility of S. suis isolates was found to amoxicillin, in combination with clavulanic acid and sulfamethoxazole potentiated with trimethoprim. None of the tested isolates were resistant to these antimicrobial substances. Only two isolates were found to be intermediately resistant to enrofloxacin in 2020. With regard to ceftiofur, one isolate was intermediately resistant in 2020 and 2022, and two isolates were intermediately resistant in 2018 and 2021. A low level of resistance was detected to ampicillin (0.6% in 2021) and to florfenicol (1.15% in 2019; 1.3% in 2022). With regard to penicillin, a medium level of resistance was detected in 2018 (10.6%), but a low level of resistance was found in the following years (7.0% in 2019; 3.1% in 2020; 3.3% in 2021; 3.9% in 2022). On the contrary, a high or very high level of resistance was found to tetracycline (66.0% in 2018; 65.1% in 2019; 44.35% in 2020; 46.4% in 2021; 54.0% in 2022). Using molecular and serological methods, serotype 7 (16.4%) was determined to be predominant among S. suis isolates, followed by serotypes 1/2, 2, 9, 4, 3, 1, 29, 16, and 31 (10.7%; 8.5%; 5.7%; 5.5%; 4.5%; 4.3%; 3.6%; 3.4%; 3.4%, respectively). Other serotypes were identified among the investigated strains either rarely (up to 10 cases) or not at all. A relatively high percentage of isolates were detected as non-typeable (79 isolates; 15.6%). Dependence of resistance upon serotype assignment could not be proven in all but serotype 31, wherein all isolates (n = 17) were resistant or intermediately resistant to clindamycin, tilmycosin, tulathromycin, and tetracycline. The resistance to clindamycin and tetracycline may be related to the high consumption of these antibiotics on pig farms at present or in previous years. Macrolides (tilmicosin and tulathromycin) and tiamulin are not suitable for the treatment of streptococcal infections, but are used on pig farms to treat respiratory infections caused by gram-negative bacteria, so they were included in the study.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kucharovicova, Ivana $u State Veterinary Institute, Rantirovska 93, 586 05 Jihlava, Czech Republic
700    1_
$a Zouharova, Monika $u Veterinary Research Institute, Hudcova 296/70, 621 00 Brno, Czech Republic
700    1_
$a Matiaskova, Katarina $u Veterinary Research Institute, Hudcova 296/70, 621 00 Brno, Czech Republic
700    1_
$a Kralova, Natalie $u Veterinary Research Institute, Hudcova 296/70, 621 00 Brno, Czech Republic $u Department of Experimental Biology, Faculty of Science, Masaryk University, Kamenice 753/5, 625 00 Brno, Czech Republic
700    1_
$a Brychta, Marek $u State Veterinary Institute, Rantirovska 93, 586 05 Jihlava, Czech Republic
700    1_
$a Simek, Bronislav $u State Veterinary Institute, Rantirovska 93, 586 05 Jihlava, Czech Republic
700    1_
$a Pecha, Tomas $u State Veterinary Institute, Rantirovska 93, 586 05 Jihlava, Czech Republic
700    1_
$a Plodkova, Hana $u State Veterinary Institute, Rantirovska 93, 586 05 Jihlava, Czech Republic
700    1_
$a Matiasovic, Jan $u Veterinary Research Institute, Hudcova 296/70, 621 00 Brno, Czech Republic
773    0_
$w MED00195446 $t Antibiotics (Basel, Switzerland) $x 2079-6382 $g Roč. 11, č. 9 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36139993 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20221010 $b ABA008
991    __
$a 20221031095249 $b ABA008
999    __
$a ind $b bmc $g 1853824 $s 1174636
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 11 $c 9 $e 20220907 $i 2079-6382 $m Antibiotics (Basel) $n Antibiotics $x MED00195446
GRA    __
$a RO0518 $p Ministry of Agriculture
GRA    __
$a QK1810193 $p Ministry of Agriculture
LZP    __
$a Pubmed-20221010

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...